ストックスクリーナーアプリを入手
14.76
1.86%
-0.28
アフターアワーズ：
14.70
-0.06
-0.41%
前日終値:
$15.04
開ける：
$14.85
24時間の取引高:
31,191
Relative Volume:
0.62
時価総額：
$2.57B
収益：
$603.63M
当期純損益:
$468.71M
株価収益率:
5.5034
EPS:
2.682
ネットキャッシュフロー:
$-59.92M
1週間 パフォーマンス:
-2.51%
1か月 パフォーマンス:
-7.05%
6か月 パフォーマンス:
-6.23%
1年 パフォーマンス:
-28.18%
1日の値動き範囲:
$14.60
$15.05
1週間の範囲:
$14.60
$15.34
52週間の値動き範囲:
$11.51
$21.25
Hutchmed China Limited Adr Stock (HCM) Company Profile
HCM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HCM
Hutchmed China Limited Adr
|
14.76 | 2.58B | 603.63M | 468.71M | -59.92M | 2.682 |
|
ZTS
Zoetis Inc
|
145.94 | 64.88B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.01 | 44.40B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.25 | 41.72B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.95 | 21.82B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
418.58 | 19.28B | 3.08B | 1.24B | 1.07B | 25.61 |
Hutchmed China Limited Adr Stock (HCM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-22 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2025-05-13 | ダウングレード | HSBC Securities | Buy → Hold |
| 2023-11-24 | アップグレード | Deutsche Bank | Hold → Buy |
| 2022-05-04 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2021-09-22 | ダウングレード | Goldman | Buy → Neutral |
| 2021-08-03 | 開始されました | Jefferies | Buy |
| 2020-10-02 | 開始されました | Deutsche Bank | Buy |
| 2020-03-13 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-02-20 | 開始されました | Goldman | Buy |
| 2019-11-19 | 開始されました | CLSA | Buy |
| 2019-10-23 | 繰り返されました | BofA/Merrill | Buy |
| 2019-07-05 | 開始されました | Macquarie | Outperform |
すべてを表示
Hutchmed China Limited Adr (HCM) 最新ニュース
Vanguard Personalized Indexing Management LLC Grows Holdings in Sandstorm Gold Ltd $SAND - Defense World
Market news - investments.halifax.co.uk
RCSHutchmed China LtdHUTCHMED Presents Data at AACR NCI EORTC - TradingView
HUTCHMED Highlights HMPL-A251 Data Presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - The Manila Times
HUTCHMED Highlights HMPL-A251 Data Presented at the - GlobeNewswire
Allianz Asset Management GmbH Sells 80,000 Shares of HUTCHMED (China) Limited Sponsored ADR $HCM - MarketBeat
Will Can Fite Biopharma Ltd Sponsored ADR stock benefit from mergersQuarterly Risk Review & Risk Controlled Stock Alerts - nchmf.gov.vn
Pfizer: CN Biopharma Sector Shows Astonishing Growth; US Drug Industry Must Collaborate with CN - AASTOCKS.com
HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress - The Manila Times
HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Why HUTCHMED (China) Limited (Common Stock) (H7T1) stock is favored by hedge fundsTrade Exit Report & Technical Entry and Exit Alerts - newser.com
Will HUTCHMED (China) Limited (Common Stock) (H7T1) stock deliver stable dividendsPortfolio Update Report & Verified Chart Pattern Signals - newser.com
BOCOMI: Trump's Additional Tariffs on Imported Innovative Drugs May Have Limited Actual Impact on CN Pharmas - AASTOCKS.com
HUTCHMED (NASDAQ:HCM) Shares Gap DownTime to Sell? - MarketBeat
M Stanley: Increased Recognition Pushes Biotech Stocks to Outpace Mkt - AASTOCKS.com
Best Momentum Stock to Buy for August 19th - MSN
National Research Corporation $NRC Shares Sold by Goldman Sachs Group Inc. - Defense World
HUTCHMED (China) Limited Sponsored ADR $HCM Stock Position Raised by Goldman Sachs Group Inc. - Defense World
HUTCHMED (NASDAQ:HCM) Shares Gap UpHere's What Happened - MarketBeat
HUTCHMED (NASDAQ:HCM) Shares Gap Up – Should You Buy? - Defense World
Price action breakdown for HUTCHMED (China) Limited Depositary Receipt2025 Dividend Review & Risk Managed Investment Strategies - newser.com
Top Blockchain Stocks To Follow Now – September 12th - Defense World
HSBC Research Positive on LT Growth of CN Biotech, Favors INNOVENT BIO/ HANSOH PHARMA - AASTOCKS.com
G Sachs Gives ST Risk Analysis for 3 Types of Firms as US Reportedly Planning to Tighten Scrutiny on CN Innovative Drugs Could Pose 'Headline Risks' for CN Pharmas - AASTOCKS.com
CN SASAC Advocates to Accelerate Development of Central SOEs in the Biopharmaceutical Industry, Build National Team in Such Field - AASTOCKS.com
Intraday pattern recognizer results for HUTCHMED (China) Limited Depositary Receipt2025 Biggest Moves & Trade Opportunity Analysis Reports - Newser
Combining machine learning predictions for HUTCHMED (China) Limited Depositary ReceiptQuarterly Market Review & Verified Entry Point Signals - Newser
How moving averages guide HUTCHMED (China) Limited Depositary Receipt trading2025 Retail Activity & Stepwise Trade Signal Implementation - Newser
HUTCHMED Announces Appointment of Acting Chief Executive Officer - GlobeNewswire Inc.
Solventum Corporation $SOLV Shares Sold by Russell Investments Group Ltd. - Defense World
HUTCHMED Completes Patient Enrollment of SANOVO Phase III Trial of ORPATHYS® and TAGRISSO® Combination as a First-Line Therapy for Certain Lung Cancer Patients in China - GlobeNewswire
Best Momentum Stock To Buy For August 19th - Barchart.com
How to build a custom watchlist for HUTCHMED (China) Limited Depositary Receipt2025 Price Action Summary & Verified Momentum Stock Ideas - Newser
BOCOMI Lowers HUTCHMED's TP to HKD37.6; Rating Kept Buy - AASTOCKS.com
Will HUTCHMED (China) Limited Depositary Receipt bounce back from current supportFree Oversold Recovery Opportunity Stocks - Newser
Analysts Have Conflicting Sentiments on These Healthcare Companies: Zymeworks (ZYME), HUTCHMED (HCM) and Zai Lab (ZLAB) - The Globe and Mail
Trend analysis for HUTCHMED (China) Limited Depositary Receipt this weekStock Holding Strategy Long-Term Summary Sheet - Newser
Carvana Co. (NYSE:CVNA) Major Shareholder Sells $35,236,000.00 in Stock - Defense World
Crossmark Global Holdings Inc. Sells 414 Shares of Morningstar, Inc. (NASDAQ:MORN) - Defense World
6,121 Shares in John Hancock Multifactor Large Cap ETF (NYSEARCA:JHML) Bought by Crossmark Global Holdings Inc. - Defense World
Concurrent Investment Advisors LLC Acquires New Holdings in ADMA Biologics Inc (NASDAQ:ADMA) - Defense World
Crossmark Global Holdings Inc. Has $356,000 Holdings in Nordson Corporation (NASDAQ:NDSN) - Defense World
Buenaventura Mining (NYSE:BVN) vs. Hochschild Mining (OTCMKTS:HCHDF) Head-To-Head Review - Defense World
Coinbase Global, Inc. (NASDAQ:COIN) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
HUTCHMED Gains China Approval for Innovative Lung Cancer Treatment - TipRanks
HUTCHMED Announces China Approval for ORPATHYS® in Combination with TAGRISSO® for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line EGFR Inhibitor Therapy - GlobeNewswire
HUTCHMED (NASDAQ:HCM) Rating Increased to Strong-Buy at Wall Street Zen - Defense World
Rhumbline Advisers Has $50,000 Position in HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) - Defense World
How Much Upside is Left in HUTCHMED (HCM)? Wall Street Analysts Think 73.52% - Nasdaq
HUTCHMED (China) Limited (NASDAQ:HCM) Shares Bought by Bank of America Corp DE - Defense World
Public Employees Retirement System of Ohio Has $39,000 Holdings in HUTCHMED (China) Limited (NASDAQ:HCM) - Defense World
Hutchmed China Limited Adr (HCM) 財務データ
収益
当期純利益
現金流量
EPS
0.60%
0.27%
大文字化:
|
ボリューム (24 時間):